Class IOngoingD-0429-2024
Drug recall · April 3, 2024
Treprostinil Injection recall
Why: Presence of Particulate Matter.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01
- Lots / codes
Lot#: 57014; Exp, 04/30/2024
- Quantity
- 466 vials
- Company
- Par Sterile Products LLC, Rochester, MI
- Distribution
- Nationwide in the USA
- Initiated
- March 4, 2024 · Voluntary: Firm initiated
- Classified
- March 28, 2024
- Reported
- April 3, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.